Ignacio Wistuba, MD

Elucidation of the molecular abnormalities involved in the pathogenesis and progression of lung cancer and other solid tumors, and the development of predictive biomarkers for novel therapies, including targeted therapy and immunotherapy,

Associations

• Translational Pathology
• Molecular Medicine Program

pathogenesis and progression of lung cancer and other solid tumors. His research interests also include identifying new molecular targets, validating biomarkers for targeted therapy and immunotherapy, and identifying molecular markers associated with lung cancer and other solid tumors development, progression and metastasis development using annotated human specimens.

• Ozirmak Lermi N, Molina Ayala M, Hernandez S, Lu W, Khan K, Serrano A, Lubo I, Hamana L, Tomczak K, Barnes S, Dou J, Liang Q, Raso MG, Tang X, Jiang M, Sanchez-Espiridion B, Weissferdt A, Heymach J, Zhang J, Sepesi B, Cascone T, Tsao A, Altan M, Mehran R, Gibbons D, Wistuba I, Haymaker C, Chen K, Solis Soto LM. Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples. Nat Commun. 2025 Sep.16(1):8499. Pubmedid: 41006245. Pmcid: PMC12474935.

• Title: SWOG Network Group Operations Center of the NCTN
  Award Number: 5U10CA180888-11 REVISED
  Sponsor: National Cancer Institute (NCI)
  Wistuba, I. (PD/PI)